New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
09:10 EDTSIRI, ZGNX, BODY, ACHN, EBIX, RVLT, PLUG, ULTA, GIS, ARO, LMCA, FSYSOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Ulta Salon (ULTA), up 6%... Ebix (EBIX), up 7.5%... Revolution Lighting (RVLT), up 12%. ALSO HIGHER: Liberty Media (LMCA), up 7% after announcing plans for two new tracking stock groups, saying its offer for Sirius XM (SIRI) is no longer applicable... Achillion (ACHN), up 4.4% after announcing clinical results for ACH-3102. DOWN AFTER EARNINGS: Aeropostale (ARO), down 15%... Fuel Systems (FSYS), down 13%. ALSO LOWER: Sirius XM, down 1.5% after Liberty Media said its offer for Sirius was no longer applicable... General Mills (GIS), down 3.2% after warning on Q3 earnings... Plug Power (PLUG), down 3% following downgrades at Cowen and Roth Capital... Body Central (BODY), down 10% after to delay filing 10-K... Zogenix (ZGNX), down 7.4% following report that Senator Manchin introduced a bill to ban Zohydro.
News For SIRI;LMCA;ARO;GIS;ULTA;PLUG;RVLT;EBIX;ACHN;BODY;ZGNX;FSYS From The Last 14 Days
Check below for free stories on SIRI;LMCA;ARO;GIS;ULTA;PLUG;RVLT;EBIX;ACHN;BODY;ZGNX;FSYS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 29, 2014
07:27 EDTPLUGPlug Power up 12.3% after confirming follow-on GenKey order from Wal-Mart
Subscribe for More Information
07:25 EDTPLUGPlug Power confirms follow-on GenKey order from Wal-Mart
Plug Power (PLUG) confirms the company has received a follow-on GenKey purchase order from Wal-Mart (WMT) to add an additional, seventh, GenKey site to the original six-site contract it announced in February. This additional site in Sterling, IL consists of 286 GenDrive fuel cell units and is planned to deploy in Q3. The add-on Sterling, Illinois GenKey site is currently in the planning stages and is expected to be deployed by the end of Q3.
07:05 EDTSIRISirius XM backs FY14 revenue $4.1B, consensus $4.13B
Subscribe for More Information
07:04 EDTSIRISirius XM reports Q2 net subscriber additions were 475,472
The total paid subscriber base reached a record 26.3M, up 5% from a year earlier. Self-pay net subscriber additions were 379,711, and the self-pay subscriber base reached a record high of 21.6M, up 7% from the second quarter of 2013. Paid and unpaid trials combined to produce a total trial funnel of 7.3M at the end of the second quarter.
07:04 EDTSIRISirius XM reports Q2 EPS 2c, consensus 2c
Subscribe for More Information
July 28, 2014
15:47 EDTSIRINotable companies reporting before tomorrow's open
Subscribe for More Information
July 25, 2014
08:01 EDTZGNXZogenix price target lowered to $3.50 from $5 at Stifel
Subscribe for More Information
July 24, 2014
15:33 EDTEBIXEbix head of investor relations 'abruptly departs,' Gotham City Research says
Subscribe for More Information
05:49 EDTSIRIStocks with implied volatility movement; TLM SIRI
Stocks with implied volatility movement; Talisman Energy (TLM) 53, Sirius XM (SIRI) 26 according to iVolatility.
July 23, 2014
16:56 EDTZGNXZogenix competitor gets FDA approval for abuse-deterrent ER oxycodone
The FDA approved Targiniq ER, an extended-release/long-acting opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Targiniq ER is the second ER/LA opioid analgesic with FDA-approved labeling describing the productís abuse-deterrent properties consistent with the FDAís 2013 draft guidance for industry, the FDA stated. The FDA is requiring postmarketing studies of Targiniq ER, to assess the serious risks of misuse, abuse, increased sensitivity to pain, addiction, overdose, and death associated with long term use beyond 12 weeks. The FDA is also requiring postmarketing studies to further assess the effects of the abuse-deterrent features on the risk for abuse of Targiniq ER. In addition, Targiniq ER is part of the ER/LA Opioid Analgesics Risk Evaluation and Mitigation Strategy. Targiniq ER is manufactured by Purdue Pharma. Zogenix has a competing pain killer drug called Zohydro ER.
15:31 EDTLMCAMalone sees Time Warner bid unlikely from tech companies, WSJ reports
Subscribe for More Information
15:00 EDTLMCALiberty Media's Malone sees tech players unlikely to bid Time Warner, DJ says
Subscribe for More Information
July 22, 2014
10:02 EDTPLUGChina to replace new-energy vehicle subsidies with new program, China Daily says
China will launch more fiscal support policies for "new-energy" vehicles for 2016 to 2020 when the current subsidy program expired at the end of 2015, said China Daily, citing a notice the State Council released Monday. New-energy vehicles include pure electric ones, plug-in hybrids and fuel cell vehicles, the report noted. Makers of electric vehicles include Kandi (KNDI) and Tesla (TSLA) and companies in the fuel cell space include Plug Power (PLUG), FuelCell Energy (FCEL) and Ballard Power (BLDP). Reference Link
July 21, 2014
13:18 EDTULTAUlta Salon mentioned positively at ITG Research
Subscribe for More Information
13:17 EDTRVLTRevolution Lighting enters into strategic distribution partnership with Ganga
Subscribe for More Information
July 18, 2014
15:23 EDTPLUGJapan to provide generous subsidies for fuel cell vehicles, Nikkei says
Subscribe for More Information
12:36 EDTPLUGPlug Power said to be on list of companies probed by SEC, Probes Reporter says
Subscribe for More Information
10:15 EDTPLUGPlug Power advances after analyst says outlook has improved
Subscribe for More Information
08:58 EDTPLUGPlug Power outlook has improved, says Roth Capital
Subscribe for More Information
06:08 EDTPLUGPlug Power implied volatility of 93 at lower end of index mean range
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use